Clinical Genetic Test
offered by
GTR Test Accession:
Help
GTR000569387.5
CAP
Last updated in GTR:
2024-06-28
View version history
GTR000569387.5,
last updated:
2024-06-28
GTR000569387.4,
last updated:
2023-07-03
GTR000569387.3,
last updated:
2022-07-12
GTR000569387.2,
last updated:
2021-07-13
GTR000569387.1,
registered in GTR:
2019-10-24
Last annual review date for the lab: 2024-06-28
LinkOut
At a Glance
Test purpose:
Help
Risk Assessment;
Screening
Conditions (1):
Help
Coronary artery disease, susceptibility to
Genes (1):
Help
LPA (6q25.3-26)
Methods (1):
Help
Molecular Genetics - Targeted variant analysis: PCR
Target population: Help
This test identifies individuals at risk for elevated plasma lipoprotein …
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Test short name:
Help
LPA Intron-25 Genotype
Specimen Source:
Help
- Peripheral (whole) blood
- View specimen requirements
Who can order: Help
- Licensed Physician
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
Test development:
Help
Test developed by laboratory but exempt from FDA oversight (eg. NYS CLEP approved, offered within a hospital or clinic)
Informed consent required:
Help
Based on applicable state law
Test strategy:
Help
http://www.questdiagnostics.com/
Pre-test genetic counseling required:
Help
No
Post-test genetic counseling required:
Help
No
Recommended fields not provided:
Lab contact for this test
Conditions
Help
Total conditions: 1
| Condition/Phenotype | Identifier |
|---|
Test Targets
Genes
Help
Total genes: 1
| Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
|---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Targeted variant analysis
PCR
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Risk Assessment;
Screening
Target population:
Help
This test identifies individuals at risk for elevated plasma lipoprotein (a) [Lp (a)] and increased cardiovascular risk.
Recommended fields not provided:
Clinical validity,
Clinical utility,
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
analytical validity = 99%
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
No
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
No
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
FDA exercises enforcement discretion
Additional Information
Reviews:
Clinical resources:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.